Pre-treatment of the beta3-adrenergic receptor agonist BRL37344 reduces in vivo myocardial ischemia/reperfusion injury by improving AMPK and SIRT1 activity and by suppressing mTOR and p70S6K signaling pathways
DOI:
https://doi.org/10.1590/Keywords:
Adenosine monophosphate-activated protein kinase (AMPK);, Beta3-adrenergic receptors;, Myocardial Ischemia/Reperfusion;, Mammalian target of rapamycin (mTOR);, Sirtuin 1 (SIRT1)Abstract
This study aimed to investigate the role and signaling pathways of β3-AR in myocardial ischemia/reperfusion (I/R) injury, which is one of the leading causes of death worldwide. 47 male rats were randomly divided into two main groups to evaluate infarct size and molecular parameters. Rats in both groups were randomly divided into 4 groups. Control (sham), I/R (30 min ischemia/120 min reperfusion), BRL37344 (BRL) (A) (5 µg/kg single-dose pre-treatment (preT) before I/R) and BRL (B) (5 µg/kg/day preT for 10 days before I/R). Infarct size was determined with triphenyltetrazolium chloride staining and analyzed with ImageJ program. The levels of AMPK, SIRT1, mTOR, and p70SK6 responsible for cellular energy and autophagy were evaluated by western blot. Infarct size increased in the I/R group (44.84 ± 1.47%) and reduced in the single-dose and 10-day BRL-treated groups (32.22 ± 1.57%, 29.65 ± 0.55%; respectively). AMPK and SIRT1 levels were decreased by I/R but improved in the treatment groups. While mTOR and p70S6K levels increased in the I/R group, they decreased with BRL preT. BRL preT protects the heart against I/R injury. These beneficial effects are mediated in part by activation of AMPK and SIRT1, inhibition of mTOR and p70S6K, and consequently protected autophagy.
Downloads
References
Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res. 2007;100(10):1512-21.
Aragón JP, Condit ME, Bhushan S, Predmore BL, Patel SS, Grinsfelder DB, et al. Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J Am Coll Cardiol. 2011;58(25):2683-91.
Balligand JL. Cardiac salvage by tweaking with beta-3- adrenergic receptors. Cardiovasc Res. 2016;111(2):128-33.
García-Prieto J, García-Ruiz JM, Sanz-Rosa D, Pun A, García-Alvarez A, Davidson SM, et al. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. Basic Res Cardiol. 2014;109(4):422.
Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H. Functional beta3-adrenoceptor in the human heart. J Clin Invest. 1996;98(2):556-62.
Giovannini L, Bianchi S. Role of nutraceutical SIRT1 modulators in AMPK and mTOR pathway: Evidence of a synergistic effect. Nutrition. 2017;34:82-96.
Hausenloy DJ, Tsang A, Yellon DM. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med. 2005;15(2):69-75.
Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92-100.
Hsu CP, Zhai P, Yamamoto T, Maejima Y, Matsushima S, Hariharan N, et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation. 2010;122(21):2170-82.
Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115(5):577-90.
Ma S, Wang Y, Chen Y, Cao F. The role of the autophagy in myocardial ischemia/reperfusion injury. Biochim Biophys Acta. 2015;1852(2):271-6.
Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007;100(6):914-22.
Meley D, Bauvy C, Houben-Weerts JH, Dubbelhuis PF, Helmond MTJ, Codogno P, et al. AMP-activated protein kinase and the regulation of autophagic proteolysis. J Biol Chem. 2006;281(46):34870-79.
Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL. Upregulation of beta (3)‐adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation. 2001;103(12):1649-55.
Morano M, Angotti C, Tullio F, Gambarotta G, Penna C, Pagliaro P, et al. Myocardial ischemia/reperfusion upregulates the transcription of the Neuregulin1 receptor ErbB3, but only postconditioning preserves protein translation: role in oxidative stress. Int J Cardiol. 2017;233:73-79
Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88(2):581-609.
Mutlu GK, Inan EA, Karaomerlioglu I, Altan MV, Yersal N, Korkusuz P, et al. Role of the β 3-adrenergic receptor subtype in catecholamine-induced myocardial remodeling. Mol Cell Biochem. 2018;446(1-2):149-60.
Niu X, Watts VL, Cingolani OH, Sivakumaran V, Leyton- Mange JS, Ellis CL, et al. Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J Am Coll Cardiol. 2012;59(22):1979-87.
Niu X, Zhao L, Li X, Xue Y, Wang B, Lv Z, et al. Beta3- Adrenoreceptor stimulation protects against myocardial infarction injury via eNOS and nNOS activation. PLoS One. 2014;9(6):e98713.
Pala R, Orhan C, Tuzcu M, Sahin N, Ali S, Cinar V, et al. Coenzyme Q10 Supplementation Modulates NFκB and Nrf2 pathways in exercise training. J Sports Sci Med. 2016;15(1):196-203.
Sahna E, Parlakpınar H, Turkoz Y, Acet A. Protective effects of melatonin on myocardial ischemia reperfusion induced infarct size and oxidative changes. Physiol Res. 2005;54(2):491-95.
Salie R, Alsalhin AKH, Marais E, Lochner A. Cardioprotective effects of beta3-adrenergic receptor (β3- AR) pre-, per-, and post-treatment in ischemia-reperfusion. Cardiovasc Drugs Ther. 2019;33(2):163-77.
Tanno M, Kuno A, Horio Y, Miura T. Emerging beneficial roles of sirtuins in heart failure. Basic Res Cardiol. 2012;107(4):273-87.
Wang ZL, Sun XC, Luo R, Li DY, Xuan HC. The expression and role of β3AR protein in myocardial ischemia/reperfusion in rats. Arch Med Sci. 2021;25(1):31-46.
Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A. 2005;102(39):13807-12.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
